Dose–Response Curves and the Determination of IC50 and EC50 Values

IF 6.8 1区 医学 Q1 CHEMISTRY, MEDICINAL Journal of Medicinal Chemistry Pub Date : 2024-10-01 DOI:10.1021/acs.jmedchem.4c02052
Bharath Srinivasan, Matthew D. Lloyd
{"title":"Dose–Response Curves and the Determination of IC50 and EC50 Values","authors":"Bharath Srinivasan, Matthew D. Lloyd","doi":"10.1021/acs.jmedchem.4c02052","DOIUrl":null,"url":null,"abstract":"Figure 1. Example dose–response curves for the inhibition of bovine alkaline phosphatase by sodium orthovanadate (169 nM to 100 μM). Assays (200 μL) were conducted in a 96-well plate in 50 mM Tris-HCl, 400 mM mannitol, 6 mM MgCl<sub>2</sub>, pH 8.24, 40 μM 4-nitrophenyl phosphate substrate, 1.5% (v/v) DMSO, and 20.2 ng of enzyme per assay. The change in absorbance was monitored at 405 nm. (16) (<b>A</b>). Dose–response curve plotted with log<sub>10</sub> [drug (M)] (parametric). (<b>B</b>). The same data plotted with molar drug concentrations (nonparametric). The determined log<sub>10</sub> IC<sub>50</sub> value is −6.7087, corresponding to an IC<sub>50</sub> of 1.95 × 10<sup>–7</sup> M and an <i>h</i>-coefficient of 0.91. Data are means ± SD. This article references 16 other publications. This article has not yet been cited by other publications.","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":6.8000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.4c02052","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Figure 1. Example dose–response curves for the inhibition of bovine alkaline phosphatase by sodium orthovanadate (169 nM to 100 μM). Assays (200 μL) were conducted in a 96-well plate in 50 mM Tris-HCl, 400 mM mannitol, 6 mM MgCl2, pH 8.24, 40 μM 4-nitrophenyl phosphate substrate, 1.5% (v/v) DMSO, and 20.2 ng of enzyme per assay. The change in absorbance was monitored at 405 nm. (16) (A). Dose–response curve plotted with log10 [drug (M)] (parametric). (B). The same data plotted with molar drug concentrations (nonparametric). The determined log10 IC50 value is −6.7087, corresponding to an IC50 of 1.95 × 10–7 M and an h-coefficient of 0.91. Data are means ± SD. This article references 16 other publications. This article has not yet been cited by other publications.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
剂量-反应曲线以及 IC50 和 EC50 值的确定
图 1.原钒酸钠(169 nM 至 100 μM)抑制牛碱性磷酸酶的剂量-反应曲线示例。测定(200 μL)在 96 孔板中进行,pH 8.24,50 mM Tris-HCl,400 mM 甘露醇,6 mM MgCl2,40 μM 4-硝基苯磷酸底物,1.5%(v/v)二甲基亚砜,每次测定 20.2 纳克酶。在 405 纳米波长处监测吸光度的变化。(16) (A).剂量-反应曲线与 log10 [药物 (M)](参数)。(B).用摩尔药物浓度绘制的相同数据(非参数)。确定的 log10 IC50 值为 -6.7087,对应的 IC50 为 1.95 × 10-7 M,h 系数为 0.91。数据为平均值 ± SD。本文引用了 16 篇其他出版物。本文尚未被其他出版物引用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry 医学-医药化学
CiteScore
4.00
自引率
11.00%
发文量
804
审稿时长
1.9 months
期刊介绍: The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents. The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.
期刊最新文献
Fragment Addition-Based Design of Heteroaromatic-Biphenyl-DAPYs as Potent and Orally Available Non-nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Enhanced Safety. Dose–Response Curves and the Determination of IC50 and EC50 Values Selective and Orally Bioavailable c-Met PROTACs for the Treatment of c-Met-Addicted Cancer Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B Correction to “Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1